Featured Article
Boston Scientific, a global medical technology company, had a strongly positive Q1 2024. Revenue rose 14% to $3.9 billion and earnings before interest and taxes rose 22 % to $674 million over the same period last year. A review of Boston Scientific’s 24 April earnings call and associated financial reports provided insight regarding the importance of pricing on performance. Pricing was not mentioned in their earnings call. Margins were briefly mentioned by…
Read MoreIn This Issue
Adobe, a visual creativity software-as-a-service company, had a positive Q2 2024. Revenue rose 10 % to $5.3 billion and earnings before interest…
Read More
D.R. Horton, a residential housing developer, had a positive Q3 2024. Revenue rose 5.8% to $9.2 billion and earnings before interest and…
Read More
J.B. Hunt, a trucking and logistics company, had a negative Q2 2024. Revenue fell 6.5 % to $2.9 billion and earnings before…
Read More
Netflix, a video-on-demand subscription service, had a highly positive Q2 2024. Revenue rose 17 % to $9.6 billion and earnings before interest…
Read More